ArticleJournal of clinical medicine2026

Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group.

Emine Bihter Eniseler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.